FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310494018> ?p ?o ?g. }

• W4310494018 abstract "Although guidelines provide excellent expert guidance for managing patients with septic shock, they leave room for personalization according to patients' condition. Hemodynamic monitoring depends on the evolution phase: salvage, optimization, stabilization, and de-escalation. Initially during the salvage phase, monitoring to identify shock etiology and severity should include arterial pressure and lactate measurements together with clinical examination, particularly skin mottling and capillary refill time. Low diastolic blood pressure may trigger vasopressor initiation. At this stage, echocardiography may be useful to identify significant cardiac dysfunction. During the optimization phase, echocardiographic monitoring should be pursued and completed by the assessment of tissue perfusion through central or mixed-venous oxygen saturation, lactate, and carbon dioxide veno-arterial gradient. Transpulmonary thermodilution and the pulmonary artery catheter should be considered in the most severe patients. Fluid therapy also depends on shock phases. While administered liberally during the resuscitation phase, fluid responsiveness should be assessed during the optimization phase. During stabilization, fluid infusion should be minimized. In the de-escalation phase, safe fluid withdrawal could be achieved by ensuring tissue perfusion is preserved. Norepinephrine is recommended as first-line vasopressor therapy, while vasopressin may be preferred in some patients. Essential questions remain regarding optimal vasopressor selection, combination therapy, and the most effective and safest escalation. Serum renin and the angiotensin I/II ratio may identify patients who benefit most from angiotensin II. The optimal therapeutic strategy for shock requiring high-dose vasopressors is scant. In all cases, vasopressor therapy should be individualized, based on clinical evaluation and blood flow measurements to avoid excessive vasoconstriction. Inotropes should be considered in patients with decreased cardiac contractility associated with impaired tissue perfusion. Based on pharmacologic properties, we suggest as the first test a limited dose of dobutamine, to add enoximone or milrinone in the second line and substitute or add levosimendan if inefficient. Regarding adjunctive therapies, while hydrocortisone is nowadays advised in patients receiving high doses of vasopressors, patients responding to corticosteroids may be identified in the future by the analysis of selected cytokines or specific transcriptomic endotypes. To conclude, although some general rules apply for shock management, a personalized approach should be considered for hemodynamic monitoring and support." @default.
• W4310494018 created "2022-12-11" @default.
• W4310494018 creator A5005772220 @default.
• W4310494018 creator A5043482559 @default.
• W4310494018 creator A5047676849 @default.
• W4310494018 creator A5053558278 @default.
• W4310494018 creator A5070798527 @default.
• W4310494018 creator A5073578820 @default.
• W4310494018 creator A5077939899 @default.
• W4310494018 creator A5086871368 @default.
• W4310494018 creator A5087628395 @default.
• W4310494018 date "2022-12-01" @default.
• W4310494018 modified "2023-10-06" @default.
• W4310494018 title "A plea for personalization of the hemodynamic management of septic shock" @default.
• W4310494018 cites W1904627470 @default.
• W4310494018 cites W1963753412 @default.
• W4310494018 cites W1969367601 @default.
• W4310494018 cites W1973976410 @default.
• W4310494018 cites W1980899995 @default.
• W4310494018 cites W2016219167 @default.
• W4310494018 cites W2027211149 @default.
• W4310494018 cites W2029411057 @default.
• W4310494018 cites W2029557661 @default.
• W4310494018 cites W2030910315 @default.
• W4310494018 cites W2049422525 @default.
• W4310494018 cites W2057364247 @default.
• W4310494018 cites W2060304193 @default.
• W4310494018 cites W2063443166 @default.
• W4310494018 cites W2063603479 @default.
• W4310494018 cites W2065926238 @default.
• W4310494018 cites W2067090053 @default.
• W4310494018 cites W2074693408 @default.
• W4310494018 cites W2082384979 @default.
• W4310494018 cites W2087817212 @default.
• W4310494018 cites W2095944485 @default.
• W4310494018 cites W2096350581 @default.
• W4310494018 cites W2100845311 @default.
• W4310494018 cites W2108153775 @default.
• W4310494018 cites W2110579824 @default.
• W4310494018 cites W2111883268 @default.
• W4310494018 cites W2136372320 @default.
• W4310494018 cites W2139351862 @default.
• W4310494018 cites W2180690155 @default.
• W4310494018 cites W2257027299 @default.
• W4310494018 cites W2293221097 @default.
• W4310494018 cites W2341968301 @default.
• W4310494018 cites W2346391051 @default.
• W4310494018 cites W2377505322 @default.
• W4310494018 cites W2408440877 @default.
• W4310494018 cites W2489536306 @default.
• W4310494018 cites W2529283167 @default.
• W4310494018 cites W2553631662 @default.
• W4310494018 cites W2602745009 @default.
• W4310494018 cites W2614578436 @default.
• W4310494018 cites W2625069600 @default.
• W4310494018 cites W267334685 @default.
• W4310494018 cites W2789446953 @default.
• W4310494018 cites W2795168521 @default.
• W4310494018 cites W2804956778 @default.
• W4310494018 cites W2810109598 @default.
• W4310494018 cites W2811050830 @default.
• W4310494018 cites W2898163423 @default.
• W4310494018 cites W2898483928 @default.
• W4310494018 cites W2899937596 @default.
• W4310494018 cites W2901165032 @default.
• W4310494018 cites W2912774204 @default.
• W4310494018 cites W2914328310 @default.
• W4310494018 cites W2923965910 @default.
• W4310494018 cites W2935331834 @default.
• W4310494018 cites W2944740795 @default.
• W4310494018 cites W2946164322 @default.
• W4310494018 cites W2949053656 @default.
• W4310494018 cites W2968386157 @default.
• W4310494018 cites W2968584677 @default.
• W4310494018 cites W2978101814 @default.
• W4310494018 cites W2985332844 @default.
• W4310494018 cites W2995970464 @default.
• W4310494018 cites W3005570206 @default.
• W4310494018 cites W3008040894 @default.
• W4310494018 cites W3015382273 @default.
• W4310494018 cites W3016605218 @default.
• W4310494018 cites W3040546271 @default.
• W4310494018 cites W3053240236 @default.
• W4310494018 cites W3080265800 @default.
• W4310494018 cites W3086677680 @default.
• W4310494018 cites W3087271483 @default.
• W4310494018 cites W3121255486 @default.
• W4310494018 cites W3154360134 @default.
• W4310494018 cites W3202964273 @default.
• W4310494018 cites W3212948591 @default.
• W4310494018 cites W4254170669 @default.
• W4310494018 cites W4281719596 @default.
• W4310494018 cites W4283011822 @default.
• W4310494018 cites W4291284042 @default.
• W4310494018 doi "https://doi.org/10.1186/s13054-022-04255-y" @default.
• W4310494018 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36457089" @default.
• W4310494018 hasPublicationYear "2022" @default.
• W4310494018 type Work @default.
• W4310494018 citedByCount "12" @default.
• W4310494018 countsByYear W43104940182023 @default.

• next